Colossal Biosciences Reportedly Seeks New Capital at $20B-$30B Valuation
Colossal Biosciences, a startup focused on de-extinction, is reportedly in talks to raise new capital. This fundraising initiative could potentially value the company between $20 billion and $30 billion. Such a valuation would mark a significant increase, doubling or tripling its previous valuation.
The de-extinction startup Colossal Biosciences is reportedly in discussions to secure new capital. These talks suggest a potential valuation for the company ranging from $20 billion to $30 billion.
Should the company achieve this reported valuation, it would represent a substantial increase, doubling or tripling its prior valuation.
According to TechCrunch, these details regarding the startup's fundraising efforts and projected valuation are based on a recent report.
